[Pharmacological principles of the therapy using adrenergic receptor inhibitors].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000818:Animals; D004285:Dogs; D006168:Guinea Pigs; D006325:Heart Atria / Q000201:enzymology; D008099:Liver / Q000201:enzymology; D009132:Muscles / Q000201:enzymology; D009638:Norepinephrine / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011674:Pulse; D051381:Rats; D013564:Sympathetic Nervous System / Q000201:enzymology; D013565:Sympatholytics / Q000627:therapeutic use*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D013565:Sympatholytics; D011433:Propranolol; D010208:Papaverine; D009638:Norepinephrine
Pharmakologische Grundlagen der Therapie mit Hemmstoffen adrenerger Rezeptoren.